2023-12-22T15:42:31-06:00 2022-12-31 873231666 PKF O'CONNOR DAVIES ADVISORY LLC 245 PARK AVENUE 12TH FLOOR NEW YORK NY 10167 990 2022-01-01 832004089 SINGULA INSTITUTE SING 2125315826 353 LEXINGTON AVENUE SUITE 600 NEW YORK NY 10016 MARC S LENER MD CHIEF EXECUTIVE OFFICER 2125315826 2023-12-22 1 MARC LENER MD 999009999 1 EVA MRUK P00543254 2122862600 2023-12-13 3 AAL1 IAL1 2022 2023-04-26 12:10:37Z X MARC S LENER MD 353 LEXINGTON AVENUE SUITE 600 NEW YORK NY 10016 238740 0 X WWW.SINGULAINSTITUTE.ORG X 2018 NY TO PERFORM RESEARCH ON CLINICAL CARE USING DATA AND TECHNOLOGY, CLINICAL MANAGEMENT, AND EDUCATION TO COMMUNITIES ABOUT MENTAL HEALTH. 10 10 3 25 0 0 133647 238740 0 0 0 0 0 0 133647 238740 0 0 0 0 34556 95535 0 0 23266 33212 187671 67768 283206 65879 -44466 196070 153782 0 2178 196070 151604 X THE MISSION OF SINGULA INSTITUTE IS TO PROMOTE MENTAL HEALTH AND WELLNESS IN THE COMMUNITY THROUGH THE DEVELOPMENT OF A CLINICAL AND RESEARCH INSTITUTE TO UNDERSTAND AN INDIVIDUAL'S RISK FOR MENTAL ILLNESS AND TO TAILOR INTERVENTIONS BASED ON THE INDIVIDUAL'S UNIQUE COMBINATION OF BIOLOGICAL AND CLINICAL VARIABLES. USING SINGLE-SUBJECT RESEARCH DESIGN, WE PLAN TO USE INNOVATIVE COMPUTATIONAL METHODS, PSYCHOPHYSIOLOGICAL TESTS, AND CLINICAL ASSESSMENTS IN ORDER TO INTEGRATE AND EXTEND UPON EXISTING METHODS OF CLINICAL CARE (SPECIFICALLY, MEDICATIONS AND PSYCHOTHERAPY). WE ALSO PLAN TO BUILD A DATA REPOSITORY AND COLLABORATE WITH ACADEMIC AND NON-ACADEMIC PARTNERS TO IMPROVE TREATMENT ALTERNATIVES. 0 0 90091 0 0 CLINICAL RESEARCH PROJECTS:OUR BOARD MEMBERS AND ADVISORS WORKED TOGETHER ON FURTHER DEVELOPING GOALS AND ANTICIPATED OUTCOMES OF CLINICAL RESEARCH AS PART OF A CLINICAL RESEARCH WORKING COMMITTEE. OUR MAIN CLINICAL RESEARCH PROTOCOL WAS SUBMITTED TO AND APPROVED BY OUR INSTITUTIONAL REVIEW BOARD AND PUBLISHED ON CLINICALTRIALS.GOV. 20189 0 0 HEALTHCARE OPERATIONS:INFORMATION TECHNOLOGY, HUMAN RESOURCES, FACILITIES, AND COMPLIANCE INFRASTRUCTURES WERE CREATED IN ORDER TO LAUNCH THE CLINICAL RESEARCH PROGRAM ALONGSIDE THE DEVELOPMENT OF BUSINESS DEVELOPMENT AND OPERATIONAL PLANS. 2910 0 0 EDUCATIONAL RESOURCES:DR. MARC LENER AND THE MARKETING AND COMMUNICATIONS WORKING COMMITTEE CONTINUED TO CONTRIBUTE MEDICAL KNOWLEDGE TO A WIDE VARIETY OF PROFESSIONAL AND EDUCATIONAL ONLINE PUBLICATIONS AND PLATFORMS WHICH ARE DISTRIBUTED FREE TO THE PUBLIC ONLINE. 0 0 0 STUDENT INTERNSHIPS:UNDERGRADUATE AND GRADUATE STUDENT INTERNS HAVE WORKED WITH US COVERING A BROAD ARRAY OF INTERESTS AND NEEDS, SUCH AS PUBLIC HEALTH, HEALTHCARE BUSINESS, AND MARKETING AND COMMUNICATIONS. 0 0 0 EDUCATIONAL TALKS:AS PART OF THE SOCIAL IMPACT PROGRAM OFFERING FROM SINGULA, DR. MARC LENER PROVIDED SEVERAL TALKS IN THE NEW YORK METROPOLITAN AREA TO SPEAK ABOUT MENTAL HEALTHCARE AND COMMUNITY PROGRAMMING.ON TUESDAY, MAY 10TH, 2022, DR. MARC LENER GAVE A TALK AT AN EVENT HOSTED BY THE SAKS FIFTH AVENUE FOUNDATION AND BRING CHANGE TO MIND, AS PART OF A PANEL DISCUSSION WITH HR PROFESSIONALS TO DISCUSS THE MENTAL HEALTH NEEDS AT THE WORKPLACE. DR. LENER SPOKE ABOUT THE SHARED RESPONSIBILITY OF THE EMPLOYER AND EMPLOYEE TO CARE FOR THE MENTAL HEALTH OF THEIR ORGANIZATION. THERE WERE ROUGHLY 350 EMPLOYEES IN ATTENDANCE.ON MAY 26TH, 2022, AT THE NASDAQ BELL CLOSING, DR. MARC LENER GAVE A TALK ON THE IMPORTANCE OF ADDRESSING MENTAL HEALTH NEEDS THROUGH CLOSING SYSTEM GAPS. DURING RELEVANT AWARENESS MONTHS, NASDAQ PROVIDES SELECTED NON-PROFIT ORGANIZATIONS WITH THE OPPORTUNITY TO SPEAK ABOUT THEIR MISSION. IN THE LEARNING MENTAL HEALTH SYSTEM THAT SINGULA INSTITUTE PROPOSES TO BUILD, DR. LENER PROPOSES A NEW DIAGNOSTIC SYSTEM BASED ON BIOPSYCHOSOCIAL ASPECTS THAT ADDRESSES THE WHOLE PERSON IN THEIR MENTAL HEALTHCARE. A VIDEO WAS DISTRIBUTED AND MADE FREE TO THE PUBLIC THROUGH THEIR SOCIAL MEDIA ACCOUNTS.ON FRIDAY, JUNE 3RD, 2022, DR. MARC LENER GAVE A TALK AT THE 2022 GALA FOR THE BOYS & GIRLS CLUB OF NORTHERN WESTCHESTER. AS PART OF A PANEL DISCUSSION, DR. LENER ADDRESSES THE NEED FOR COMMUNITY PROGRAMS TO AID IN THE OVERALL SUPPORT FOR THOSE AT MENTAL HEALTH RISK. THERE WERE ROUGHLY 500 INVITEES IN ATTENDANCE. 0 0 0 113190 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 7 0 3 1 0 0 0 0 0 0 0 0 0 0 0 0 X 10 10 1 0 0 0 0 0 0 1 1 0 0 1 1 1 1 1 1 0 0 0 NY X X MARC S LENER MD 2125315826 353 LEXINGTON AVENUE SUITE 600 NEW YORK NY 10016 X MARC S LENER MD CEO 40.00 X X 0 0 0 BARRY PEEK ESQ CHAIR 2.00 X X 0 0 0 JOSHUA C RUBIN ESQ VICE CHAIR 3.00 X X 0 0 0 WILLIAM LANGDON SECRETARY 3.00 X X 0 0 0 CAROLINE LEE TREASURER 3.00 X X 0 0 0 KATHY ALIGENE MD DIRECTOR 1.00 X 0 0 0 DESMOND DODD DIRECTOR 3.00 X 0 0 0 ARVIND GOVINDARAJAN PHD DIRECTOR 1.00 X 0 0 0 RANDALL LEE DIRECTOR 1.00 X 0 0 0 KYLE SCHROEDER DIRECTOR 1.00 X 0 0 0 JAMIE SERINO DIRECTOR (THRU OCT 2022) 2.00 X 0 0 0 0 0 0 0 0 0 0 0 238740 238740 238740 0 0 0 X 78690 31476 47214 16845 6738 10107 1372 1372 94094 29394 45831 18869 2910 2910 3441 3441 2266 2266 53961 20984 28580 4397 7939 7939 CLINICAL RESEARCH 17839 17839 DEVELOPMENT 3259 3259 TRAINING & CERTIFICATIO 590 590 283206 113190 146750 23266 196070 153782 196070 153782 0 2178 0 2178 X 196070 151604 196070 151604 196070 153782 -44466 0 X 0 0 0 X 144218 121236 133647 238740 637841 144218 121236 133647 238740 637841 13000 15000 10500 126313 164813 0 13000 15000 10500 126313 164813 473028 144218 121236 133647 238740 637841 0.74160 0.00000 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED FORM 990, PART VI, SECTION A, LINE 2 MARC S. LENER AND KATHY ALIGENE HAVE A FAMILY RELATIONSHIP. FORM 990, PART VI, SECTION B, LINE 11B THE ORGANIZATION HAS ITS FORM 990 PREPARED BY AN OUTSIDE ACCOUNTING FIRM. THE FORM 990 IS REVIEWED BY THE CEO AND HEAD OF OPERATIONS. ONCE REVIEWED BY THE CEO AND HEAD OF OPERATIONS, A COPY IS PROVIDED TO ALL MEMBERS OF THE BOARD OF DIRECTORS FOR THEIR REVIEW AND COMMENT PRIOR TO FILING. FORM 990, PART VI, SECTION B, LINE 12C THE ORGANIZATION HAS A CONFLICT OF INTEREST POLICY APPLICABLE TO DIRECTORS, OFFICERS, AND MEMBERS OF ANY COMMITTEES WITH DELEGATED POWERS FROM THE BOARD OF DIRECTORS. IN CONNECTION WITH ANY ACTUAL OR POSSIBLE CONFLICT OF INTEREST, AN INTERESTED PERSON MUST DISCLOSE THE EXISTENCE OF THE FINANCIAL INTEREST AND BE GIVEN THE OPPORTUNITY TO DISCLOSE ALL MATERIAL FACTS TO THE DIRECTORS AND MEMBERS OF COMMITTEES WITH DELEGATED POWERS FROM THE BOARD OF DIRECTORS CONSIDERING THE PROPOSED TRANSACTION OR ARRANGEMENT. AFTER DISCLOSURE OF THE FINANCIAL INTEREST AND ALL MATERIAL FACTS, AND AFTER ANY DISCUSSION WITH THE INTERESTED PERSON, HE/SHE SHALL LEAVE THE BOARD OF DIRECTORS OR COMMITTEE MEETING WHILE THE DETERMINATION OF A CONFLICT OF INTEREST IS DISCUSSED AND VOTED UPON. THE REMAINING BOARD OR COMMITTEE MEMBERS SHALL DECIDE IF A CONFLICT OF INTEREST EXISTS. THE MINUTES OF THE BOARD OF DIRECTORS AND ALL COMMITTEES WITH BOARD-DELEGATED POWERS SHALL CONTAIN THE DISCUSSIONS AND DELIBERATION REGARDING AN ACTUAL OR POSSIBLE CONFLICT OF INTEREST. EACH DIRECTOR, OFFICER AND MEMBER OF A COMMITTEE WITH POWERS DELEGATED BY THE BOARD OF DIRECTORS SHALL ANNUALLY SIGN A STATEMENT WHICH AFFIRMS SUCH PERSON: (A) HAS RECEIVED A COPY OF THIS CONFLICT OF INTEREST POLICY, (B) HAS READ AND UNDERSTANDS THE CONFLICT OF INTEREST POLICY, (C) HAS AGREED TO COMPLY WITH THE CONFLICT OF INTEREST POLICY, AND (D) UNDERSTANDS THAT THE ORGANIZATION IS CHARITABLE AND IN ORDER TO MAINTAIN ITS FEDERAL TAX EXEMPTION IT MUST ENGAGE PRIMARILY IN ACTIVITIES WHICH ACCOMPLISH ONE OR MORE OF ITS TAX-EXEMPT PURPOSES. FORM 990, PART VI, SECTION C, LINE 19 THE ORGANIZATION MAKES ITS FORM 990, GOVERNING DOCUMENTS, AND CONFLICT OF INTEREST POLICY AVAILABLE TO THE PUBLIC UPON REQUEST. FORM 990, PART IX, LINE 11G PROJECT CONSULTANTS: PROGRAM SERVICE EXPENSES 29,394. MANAGEMENT AND GENERAL EXPENSES 45,831. FUNDRAISING EXPENSES 18,869. TOTAL EXPENSES 94,094.